Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Industry
30 Articles Available
1
2
Can't find what you're looking for? Try our
advanced search
.
Arizona Bioscience
Biotechnology Growth in Arizona
PAO-04-22-R250-04
M&A
M&A: Fundamental to Pharma Industry Growth
PAP-Q1-20-NI-002
Gene Therapy
Introduction: The Promise & Challenge of Gene Therapy
PAP-Q4-19-NI-008
Glocalization
Introduction: Glocalization
PAP-Q3-19-NI-003
FDA
The FDA Changes the Drug Approval Process
PAO-M05-19-NI-014
Biologics
Building a Biologics Business from the Ground Up
PAP-Q2-18-CL-008
FDA
Safety Concerns Raised about Valsartan from China
PAO-M07-18-NI-013
Industry Trend
China Turning to Indian Drug Manufacturers in Response to Trade War with US
PAO-M07-18-NI-011
Investment
Investing in Chinese Pharma Companies Proves Profitable
PR-M05-18-NI-023
Mergers & Acquisitions
Inside Mergers & Acquisitions
PAP-Q2-18-CL-001
Investment
Taking Middle-Market CROs and CDMOs to the Next Level
PAP-Q2-18-CL-003
Immunotherapy
Cancer Immunotherapies Reach Patients More Quickly Than Other Drugs
PAO-M05-18-NI-013
Used Equipment
With Expertise Comes Security
PA-M05-18-CL-001
Acquisition
Takeda Acquires Shire for $62 Billion
PAO-M05-18-NI-005
IPO
WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock Exchange
PR-M05-18-NI-037
Radiography
Samsung Announces Commitment to Lower Dose Exposure Within its Digital Radiography Suite
PR-M04-18-NI-98
Innovation
Pear Therapeutics and Sandoz Announce Deal to Commercialize Prescription Digital Therapeutics
PR-M04-18-NI-81
Industry
Casdin Capital to Become Shareholder in BioLife Solutions
PR-M04-18-NI-42
Licensing
Merck Projected to Spend the Most on Licensing Deals in 2018
PAO-M04-18-NI-003
Earnings
Allergan to Report First Quarter 2018 Earnings and Host Conference Call and Webcast
PR-M04-18-NI-012
Operational Excellence
Transforming A CDMO Using an Operational Excellence Approach
PAO-M03-18-CL-003
Clinical Trials
Clinical Trial Access to Expand Following Receipt of Additional Funding
PAO-M03-18-NI-026
Finance
WuXi Biologics Reports Remarkable 2017 Annual Results: Revenue up 63.7% to a Record High of RMB1,618.8 Million
PR-M03-18-NI-076
Industry
Insulin Market Expected to Witness Enhanced Growth Due to Increasing Numbers of Pharmacological Firms Till 2022 | Million Insights
PR-M03-18-NI-066
1
2
»